药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chloroprocaine
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Temsirolimus.
Halothane
Satralizumab
The serum concentration of Levocetirizine can be decreased when it is combined with Satralizumab.
Halothane
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levocetirizine is combined with Oliceridine.
Halothane
Abametapir
The serum concentration of Levocetirizine can be increased when it is combined with Abametapir.
Halothane
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Levocetirizine.
Halothane
Cenobamate
The serum concentration of Levocetirizine can be decreased when it is combined with Cenobamate.
Halothane
Lasmiditan
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Lasmiditan.
Halothane
Lefamulin
Lefamulin may increase the QTc-prolonging activities of Levocetirizine.
Halothane
Entrectinib
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Entrectinib.
Halothane
Esketamine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Esketamine.
Halothane
Deoxyepinephrine
The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Levocetirizine.
Halothane
Theodrenaline
The therapeutic efficacy of Theodrenaline can be increased when used in combination with Levocetirizine.
Halothane
Racepinephrine
The therapeutic efficacy of Racepinephrine can be increased when used in combination with Levocetirizine.
Halothane
Protokylol
The therapeutic efficacy of Protokylol can be increased when used in combination with Levocetirizine.
Halothane
Levonordefrin
The therapeutic efficacy of Levonordefrin can be increased when used in combination with Levocetirizine.
Halothane
Agmatine
Agmatine may increase the anticholinergic activities of Levocetirizine.
Halothane
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione may increase the anticholinergic activities of Levocetirizine.
Halothane
Fenoterol
Fenoterol may increase the anticholinergic activities of Levocetirizine.
Halothane
Chloroprocaine
Chloroprocaine may increase the anticholinergic activities of Levocetirizine.
Halothane
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Levocetirizine.